Related references
Note: Only part of the references are listed.The emerging role of vitamin D binding protein in multiple sclerosis
Giulio Disanto et al.
JOURNAL OF NEUROLOGY (2011)
Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
A. C. Kroksveen et al.
JOURNAL OF PROTEOMICS (2011)
Vitamin D in the healthy and inflamed central nervous system: access and function
Joost Smolders et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
Manuel Comabella et al.
BRAIN (2010)
Optimizing Performance of Glycopeptide Capture for Plasma Proteomics
Frode S. Berven et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Jan Ottervald et al.
JOURNAL OF PROTEOMICS (2010)
Features of intrathecal immunoglobulins in patients with multiple sclerosis
Franziska Di Pauli et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
Marcel P. Stoop et al.
PLOS ONE (2010)
Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases
Guo Nan Yin et al.
BRAIN RESEARCH (2009)
Alteration of DBP Levels in CSF of Patients with MS by Proteomics Analysis
Zhaoyu Qin et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)
Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
Shilian Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Pharmacological treatment of early multiple sclerosis
Olaf Stueve et al.
DRUGS (2008)
Vitamin D as an immune modulator in multiple sclerosis, a review
Joost Smolders et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Neuroprotective Effect of Apolipoprotein D against Human Coronavirus OC43-Induced Encephalitis in Mice
Sonia Do Carmo et al.
JOURNAL OF NEUROSCIENCE (2008)
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution
Hasmik Keshishian et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Interaction of the N-terminal domain of the AMPA receptor GIuR4 subunit with the neuronal pentraxin NP1 mediates GluR4 synaptic recruitment
Gek-Ming Sia et al.
NEURON (2007)
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
Kassandra L. Munger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Therapeutic potential of vitamin D-binding protein
PT Gomme et al.
TRENDS IN BIOTECHNOLOGY (2004)
F3/contactin acts as a functional ligand for notch during oligodendrocyte maturation
QD Hu et al.
CELL (2003)
Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation
GR John et al.
NATURE MEDICINE (2002)
Increased intrathecal production of apolipoprotein D in multiple sclerosis
M Reindl et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study
G Comi et al.
LANCET (2001)
Apolipoprotein D
E Rassart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
LD Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
